DOCSLIB.ORG

Nocturia and Depression. BJU Int 2004; 93: 1253

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Nocturia and Depression. BJU Int 2004; 93: 1253 Appendix 1. Pubmed: 1. Asplund, R, Henriksson, S, Johansson, S et al.: Nocturia and depression. BJU Int 2004; 93: 1253. 2. Asplund, R, Johansson, S, Henriksson, S et al.: Nocturia, depression and antidepressant medication. BJU Int 2005; 95: 820. 3. Bamer, AM, Johnson, KL, Amtmann, DA et al.: Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis. Clin Epidemiol 2010; 2010: 99. 4. Barone, P, Antonini, A, Colosimo, C et al.: The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641. 5. Bauer, GE, Baker, J, Hunyor, SN et al.: Side-effects of antihypertensive treatment: a placebo-controlled study. Clin Sci Mol Med Suppl 1978; 4: 341s. 6. Biri, A, Bakar, C, Maral, I et al.: Women with and without menopause over age of 40 in Turkey: consequences and treatment options. Maturitas 2005; 50: 167. 7. Booth, J, McMillan, L: The impact of nocturia on older people - implications for nursing practice. Br J Nurs 2009; 18: 592. 8. Brostrom, A, Johansson, P, Stromberg, A et al.: Obstructive sleep apnoea syndrome--patients' perceptions of their sleep and its effects on their life situation. J Adv Nurs 2007; 57: 318. 9. Brown, JS, Subak, LL, Gras, J et al.: Urge incontinence: the patient's perspective. J Womens Health 1998; 7: 1263. 10. Bruin, VM, Bittencourt, LR, Tufik, S: Sleep-wake disturbances in Parkinson's disease: current evidence regarding diagnostic and therapeutic decisions. Eur Neurol 2012; 67: 257. 11. Bulpitt, CJ, Connor, M, Schulte, M et al.: Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life. J Hum Hypertens 2000; 14: 205. 12. Bulpitt, CJ, Dollery, CT, Carne, S: Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121. 13. Bulpitt, CJ, Dollery, CT, Hoffbrand, BI: The contribution of psychological features to the symptoms of treated hypertensive patients. Psychol Med 1977; 7: 661. 14. Chan, AK, Duh, QY, Katz, MH et al.: Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 1995; 222: 402. 15. Chatellier, G, Degoulet, P, Devries, C et al.: [Critical evaluation of the functional signs of arterial hypertension]. Arch Mal Coeur Vaiss 1982; 75 Spec No: 137. 16. Cochen De Cock, V, Abouda, M, Leu, S et al.: Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med 2010; 11: 247. 17. Comella, CL: Sleep disturbances in Parkinson's disease. Curr Neurol Neurosci Rep 2003; 3: 173. 18. Cornu, JN, Roupret, M: [Impact of nocturia on the daily life of patients with lower urinary tract symptoms due to benign prostatic hyperplasia]. Prog Urol 2007; 17: 1033. 19. Coyne, KS, Matza, LS, Brewster-Jordan, J: "We have to stop again?!": The impact of overactive bladder on family members. Neurourol Urodyn 2009; 28: 969. 20. Coyne, KS, Sexton, CC, Kopp, ZS et al.: The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int 2011; 108: 1459. 21. Coyne, KS, Wein, AJ, Tubaro, A et al.: The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 2009; 103 Suppl 3: 4. 22. Coyne, KS, Zhou, Z, Thompson, C et al.: The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003; 92: 731. 23. Crabb, L: Sleep disorders in Parkinson's disease: the nursing role. Br J Nurs 2001; 10: 42. 24. Darowski, A, Chambers, SA, Chambers, DJ: Antidepressants and falls in the elderly. Drugs Aging 2009; 26: 381. 25. De Cock, VC, Dauvilliers, Y: [How to manage daytime sleepiness associated with Parkinson's disease]. Rev Neurol (Paris) 2010; 166: 793. 26. Endeshaw, YW, Johnson, TM, Kutner, MH et al.: Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc 2004; 52: 957. 27. Fleming, WE, Pollak, CP: Sleep disorders in multiple sclerosis. Semin Neurol 2005; 25: 64. 28. Foley, DJ, Vitiello, MV, Bliwise, DL et al.: Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation '2003 Sleep in America' Poll. Am J Geriatr Psychiatry 2007; 15: 344. 29. Fujikawa, K, Kasahara, M, Matsui, Y et al.: Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scand J Urol Nephrol 2001; 35: 310. 30. Gonasun, LM, Langrall, H: Adverse reactions to pindolol administration. Am Heart J 1982; 104: 482. 31. Goodnick, PJ: Clinical and laboratory effects of discontinuation of lithium prophylaxis. Acta Psychiatr Scand 1985; 71: 608. 32. Gopal, M, Sammel, MD, Pien, G et al.: Investigating the associations between nocturia and sleep disorders in perimenopausal women. J Urol 2008; 180: 2063. 33. Gorbien, MJ: When your older patient can't sleep: how to put insomnia to rest. Geriatrics 1993; 48: 65. 34. Gourova, LW, van de Beek, C, Spigt, MG et al.: Predictive factors for nocturia in elderly men: a cross- sectional study in 21 general practices. BJU Int 2006; 97: 528. 35. Guilleminault, C, Lin, CM, Goncalves, MA et al.: A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosom Res 2004; 56: 511. 36. Hakkinen, JT, Shiri, R, Koskimaki, J et al.: Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS). J Urol 2008; 179: 1897. 37. Hayes, D, Jr., Anstead, MI, Ho, J et al.: Insomnia and chronic heart failure. Heart Fail Rev 2009; 14: 171. 38. Hermann, DM, Bassetti, CL: Sleep Apnea and Other Sleep-Wake Disorders in Stroke. Curr Treat Options Neurol 2003; 5: 241. 39. Ikemoto, I, Kiyota, H, Suzuki, Y et al.: [Roles of BPH impact index in the evaluation of impaired urination in patients with BPH]. Nihon Hinyokika Gakkai Zasshi 2005; 96: 623. 40. Isik, AT, Celik, T, Bozoglu, E et al.: Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging 2009; 13: 672. 41. Johnson, TV, Abbasi, A, Ehrlich, SS et al.: Nocturia associated with depressive symptoms. Urology 2011; 77: 183. 42. Kaminska, M, Kimoff, R, Benedetti, A et al.: Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler 2012; 18: 1159. 43. Kebebew, E, Duh, QY, Clark, OH: Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg 2003; 138: 867. 44. Kujubu, DA, Aboseif, SR: An overview of nocturia and the syndrome of nocturnal polyuria in the elderly. Nat Clin Pract Nephrol 2008; 4: 426. 45. Kupelian, V, Rosen, RC, Link, CL et al.: Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey. J Urol 2009; 181: 694. 46. Kupelian, V, Wei, JT, O'Leary, MP et al.: Nocturia and quality of life: results from the Boston area community health survey. Eur Urol 2012; 61: 78. 47. Launois, SH, Pepin, JL, Levy, P: Sleep apnea in the elderly: a specific entity? Sleep Med Rev 2007; 11: 87. 48. Liao, WC, Huang, CY, Huang, TY et al.: A systematic review of sleep patterns and factors that disturb sleep after heart surgery. J Nurs Res 2011; 19: 275. 49. Lo Coco, D, La Bella, V: Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol 2012; 19: 760. 50. Lo Coco, D, Mattaliano, P, Spataro, R et al.: Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011; 82: 839. 51. Lumachi, F, Zucchetta, P, Angelini, F et al.: Tumors of the parathyroid glands. Changes in clinical features and in noninvasive localization studies sensitivity. J Exp Clin Cancer Res 2000; 19: 7. 52. Macaulay, AJ, Stern, RS, Holmes, DM et al.: Micturition and the mind: psychological factors in the aetiology and treatment of urinary symptoms in women. Br Med J (Clin Res Ed) 1987; 294: 540. 53. Markland, AD, Vaughan, CP, Johnson, TM, 2nd et al.: Prevalence of nocturia in United States men: results from the National Health and Nutrition Examination Survey. J Urol 2011; 185: 998. 54. Marschall-Kehrel, D: Update on nocturia: the best of rest is sleep. Urology 2004; 64: 21. 55. McCrae, CS: Late-life comorbid insomnia: diagnosis and treatment. Am J Manag Care 2009; 15 Suppl: S14. 56. Menza, M, Dobkin, RD, Marin, H et al.: Sleep disturbances in Parkinson's disease. Mov Disord 2010; 25 Suppl 1: S117. 57. Mevcha, A, Gulur, DM, Gillatt, D: Diagnosing urological disorders in ageing men. Practitioner 2010; 254: 25. 58. Milsom, I, Kaplan, SA, Coyne, KS et al.: Effect of Bothersome Overactive Bladder Symptoms on Health- related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS. Urology 2012; 80: 90. 59. Morley, JE: An overview of diabetes mellitus in older persons. Clin Geriatr Med 1999; 15: 211. 60. Newman, DK: Stating the case for overactive bladder: a nurse practicioner's perspective. J Am Acad Nurse Pract 2004; 16: 1. 61. Nodel, MR: [Effects of the dopamine agonist mirapex (pramipexole) therapy on sleep disorders in Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2010; 110: 42. 62. Novi, JM, Jeronis, S, Srinivas, S et al.: Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study. J Urol 2005; 174: 937. 63. Oliveira, DS, Hachul, H, Goto, V et al.: Effect of therapeutic massage on insomnia and climacteric symptoms in postmenopausal women.
Load more

Recommended publications
  • Pharmaceutical Sciences
    IAJPS 2017, 4 (08), 2671 - 2680 V.L.Sravani et al ISSN 2349 - 7750 CODEN [USA]: IAJPBB ISSN: 2349 - 7750 I N D O A M E R I C A N J O U R N A L O F P H A R M A C E U T I C A L S C I E N C E S Available online at: http://www.iajps.com Research Article ANTI - ACNE ACTIVITY OF LIPIDO - STEROLIC EXTRACT OF SERENOA REPENS AND HYDRO - ALCOHOLIC EXTRACT OF GLYCYRRHIZA GLABRA IN SYRIAN HAMSTER EAR MODEL V. Laxmi Sravani 1 *, Dr. B. Ch a n drasekhar Rao 1 , Dr. D. Ravi Krishna Babu 2 1 Department of Pharma cology, RGR Siddhanthi College of Pharmacy , Secundera bad. 2 Aurigene Discovery Technologies Pvt Ltd. Miyapur, Hyderabad. Abstract : Acne vulgaris is the most commonly encountered dermatological disease of pilosebaceous unit. Androgens, which increase during puberty, stimulate the sebaceous gland to produce sebum and cause retention of keratinocytes around the sebaceous hair follicle orifice causing partial to complete blockage and leading to colonization with Propionibacterium acnes, which participates in the production of pro inflammatory mediators. For treatment of acne one of the approaches is to reduce sebum production, the main stimulus to acne; then all other pathogenic factors will diminish. A comprehensive approach combining the natural medicine with anti - androgenic activity would be fruitful area for anti - acne therapy. In this context the well documented anti - androgenic herbs like liquorice and saw palmetto were selected and screened in Syrian hamster ear model using spironolactone as standard.
    [Show full text]
  • THE BARRON REPORT Volume 7, Issue 6 © 1999, Jon Barron
    THE BARRON REPORT Volume 7, Issue 6 © 1999, Jon Barron. All Rights Reserved. Health For Every Man Over 30 The Prostate Problem Like women, men too are exposed to the effects of chemical estrogens in their environment. In addition, as their testosterone levels drop with age, there is, in many cases, a concomitant rise in estradiol levels -- the major reason that many older men develop breasts. Just as with women, estradiol stimulates cell growth in men too and is potentially cancerous. Estradiol stimulates the BCL2 gene, which is the gene responsible for stopping cell death. What at first glance sounds like a positive, is, upon closer inspection, not. When cell death in prostate tissue, for example, is blocked, cell growth continues unabated -- becoming a major contributing factor in the enlargement of the prostate and the development of prostate cancer. This is one of the main factors involved in the dramatically increased incidence of prostate cancer. • A new case of Prostate Cancer is diagnosed every 3 minutes in America and every 15 minutes a man dies from prostate cancer. • Prostate Cancer is the second leading type of cancer among men. • 11 million men have some form of Prostate Cancer in the United States. • African-American men have the highest rate of Prostate Cancer in the world. • Survival rates for men with prostate cancer in 1995 were no different than they were in 1965. • The age at which Prostate Cancer develops will drop ten years by the year 2000. By the year 2000, Prostate Cancer will increase by 90%. The Prostate Solution Regular use of a men's progesterone crememakes a great deal of sense for any man over the age of 30.
    [Show full text]
  • The 5ARI Withdrawal Syndrome (5ARI-WS)
    The 5ARI Withdrawal Syndrome (5ARI-WS) The Silenced Androgen Receptor (AR) Theory: Explaining persistent side effects arising from 5alpha reductase (5AR) inhibitor (5ARI) use By “Awor” and “Mew”, Administrators of Propeciahelp.com (July 2010) 1. Introduction An increasingly overwhelming amount of evidence is starting to accumulate from various doctors, scientists, patient groups and online discussion forums, whereby seemingly unrelated substances such as finasteride, dutasteride, isotretinoin and saw palmetto extract (SPE) based preparations are causing young consumers to suffer from long-term, irreversible and serious health damage. The experienced persistent side effect have a clear denominator in that they all seem to relate to physiological and psychological functions which require androgens to function correctly: Loss of libido (1) (2) Low energy, fatigue (1) Depression (including suicidal depression)* (3) (4) (5) (6) Impaired thought processes* (7) Memory failure* (7) Erectile dysfunction (8) (9) (2) Penile atrophy (9) Impaired spermatogenesis (10) (11) (12) Muscle wasting (13) (14) (15) Gynecomastia (16) Dry skin and dry eyes (17) (18) (19) Prostate problems (2) Metabolic syndrome (20) Osteoporosis (21) (22) Anxiety and sleep disorders, muscle spasms (23) (24) (25) * Indirect action through 3α-HSD as described later in this document Of substantial note is that most side effects typically surface or reach full extent roughly 10-14 days after quitting the 5ARI substances. Androgen dependent tissue atrophy (penile, scrotum,
    [Show full text]
  • Beta-Sitosterol [BSS] and Betasitosterol Glucoside [BSSG] As an Adjuvant in the Treatment of Pulmonary Tuberculosis Patients.” TB Weekly (4 Mar 1996)
    Saw Palmetto (Serenoa repens) and One of Its Constituent Sterols -Sitosterol [83-46-5] Review of Toxicological Literature Prepared for Errol Zeiger, Ph.D. National Institute of Environmental Health Sciences P.O. Box 12233 Research Triangle Park, North Carolina 27709 Contract No. N01-ES-65402 Submitted by Raymond Tice, Ph.D. Integrated Laboratory Systems P.O. Box 13501 Research Triangle Park, North Carolina 27709 November 1997 EXECUTIVE SUMMARY The nomination of saw palmetto and -sitosterol for testing is based on the potential for human exposure and the limited amount of toxicity and carcinogenicity data. Saw palmetto (Serenoa repens), a member of the palm family Arecaceae, is native to the West Indies and the Atlantic Coast of North America, from South Carolina to Florida. The plant may grow to a height of 20 feet (6.10 m), with leaves up to 3 feet (0.914 m) across. The berries are fleshy, about 0.75 inch (1.9 cm) in diameter, and blue-black in color. Saw palmetto berries contain sterols and lipids, including relatively high concentrations of free and bound sitosterols. The following chemicals have been identified in the berries: anthranilic acid, capric acid, caproic acid, caprylic acid, - carotene, ferulic acid, mannitol, -sitosterol, -sitosterol-D-glucoside, linoleic acid, myristic acid, oleic acid, palmitic acid, 1-monolaurin and 1-monomyristin. A number of other common plants (e.g., basil, corn, soybean) also contain -sitosterol. Saw palmetto extract has become the sixth best-selling herbal dietary supplement in the United States. In Europe, several pharmaceutical companies sell saw palmetto-based over-the-counter (OTC) drugs for treating benign prostatic hyperplasia (BPH).
    [Show full text]
  • Baus Section of Oncology the British Prostate Group
    Prostate Cancer and Prostatic Diseases (2006 ) 9, 310 –335 & 2006 Nature Publishing Group All rights reserved 1365-7852/06 $30.00 www.nature.com/pcan BAUS SECTION OF ONCOLOGY THE BRITISH PROSTATE GROUP PROSTATE CANCER – A MEETING OF MINDS FINAL ABSTRACTS Manchester International Convention Centre 24th – 26th November 2004 Abstracts British Prostate Group Does increasing the number of cores of prostate biopsy Anorectal dysfunction after 3-D conformal radiotherapy for 311 improve diagnostic accuracy? Indications and morbidity localised prostate cancer Kapasi F, Chandrasekar P, Barber C, Samman R, Dickon Hayne, Nula Allen, Dan Ashdown, Amanda Mellon, Potluri B and Virdi J. John Glaholm, Mike Foster Good Hope Hospital, Birmingham, Methods A study was conducted on accurate data maintained on 400 Introduction: patients who underwent transrectal ultrasound (TRUS) guided Previous work (Ref 1, 2) has shown a very high incidence of prostate biopsy. Patients were divided into three groups anorectal side effects with associated changes on anorectal depending on the number of cores and each group was physiology following conventional radiotherapy for localised subdivided into two based on the PSA level (PSA<20 & prostate cancer (CaP). We report early results on the first PSA>20). TRUS biopsy procedure was carried out using B and prospective study aiming to identify symptoms and quantify K medical ultrasound scanner no. 2002 (Panther Unit) using anorectal dysfunction after 3-D conformal radiotherapy (3D- Biplanor rectal probe (8551). An 18G, 20cm biopsy needle CRT) for CaP. (Biopty gun) was used. Patients & methods: Intravenous Gentamicin 120mg, Metronidazole 500mg Ethical approval was obtained from the North Birmingham suppository given at the time of procedure, followed by oral Regional Ethics Committee.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,486,374 B2 Tamarkin Et Al
    USOO8486374B2 (12) United States Patent (10) Patent No.: US 8,486,374 B2 Tamarkin et al. (45) Date of Patent: Jul. 16, 2013 (54) HYDROPHILIC, NON-AQUEOUS (56) References Cited PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES U.S. PATENT DOCUMENTS 1,159,250 A 11/1915 Moulton 1,666,684 A 4, 1928 Carstens (75) Inventors: Dov Tamarkin, Maccabim (IL); Meir 1924,972 A 8, 1933 Beckert Eini, Ness Ziona (IL); Doron Friedman, 2,085,733. A T. 1937 Bird Karmei Yosef (IL); Alex Besonov, 2,390,921 A 12, 1945 Clark Rehovot (IL); David Schuz. Moshav 2,524,590 A 10, 1950 Boe Gimzu (IL); Tal Berman, Rishon 2,586.287 A 2/1952 Apperson 2,617,754 A 1 1/1952 Neely LeZiyyon (IL); Jorge Danziger, Rishom 2,767,712 A 10, 1956 Waterman LeZion (IL); Rita Keynan, Rehovot (IL); 2.968,628 A 1/1961 Reed Ella Zlatkis, Rehovot (IL) 3,004,894 A 10/1961 Johnson et al. 3,062,715 A 11/1962 Reese et al. 3,067,784. A 12/1962 Gorman (73) Assignee: Foamix Ltd., Rehovot (IL) 3,092.255. A 6, 1963 Hohman 3,092,555 A 6, 1963 Horn 3,141,821 A 7, 1964 Compeau (*) Notice: Subject to any disclaimer, the term of this 3,142,420 A 7/1964 Gawthrop patent is extended or adjusted under 35 3,144,386 A 8/1964 Brightenback U.S.C. 154(b) by 1180 days. 3,149,543 A 9, 1964 Naab 3,154,075 A 10, 1964 Weckesser 3,178,352 A 4, 1965 Erickson (21) Appl.
    [Show full text]
  • Coaching for Prostate Cancer
    P A A C T, I N C. PROSTATE CANCER COMMUNICATION P PROSTATE CANCER COMM UNI CATI ON NEW SLETTER • VOLUM E 2 2, NUM BER 2 • Sep t em b er 2 00 6 FOUNDER: LLOYD J. NEY, SR. – FOUNDED 1984 President and Chairperson: WHAT THE HECK HAS BEEN GOING ON IN MY WORLD- Janet E. Ney PART 12!!! By Mark A. Moyad, M.D., M.P.H. Board of Directors: PISTONS DO NOT RULE! That is all I need to say about that - by the time Edwin Kuberski you read this article I will have finished professional mental therapy for the Treasurer second year in a row because the Pistons blew it in the playoffs. Well, there is always the Michigan football season in a few months (time to restart therapy). Newton Dilley Helen Mellema 71) I heard you are on ABC radio every Saturday from 11AM to Noon! Peter Noor Jr. Richard H. Profit Jr. Was I drinking a lot of pomegranate juice that day or are you really on Anthony Staicer this show? The show is called “The Doctor is in” with Dr. Mark Moyad and Stephen Stewart. If you go to WJR.com on Saturday mornings at 11AM to Noon East- Honorary Board Member: ern Standard time you can listen to the show live anywhere in the world on your computer. In the Midwest the radio dial is 760 AM and it is the same sta- Russell Osbun tion my father listened to when I was a kid (neat stuff)! It is a 1-hour general prevention and nutrition show and I have no idea how long it will last.
    [Show full text]
  • Supporting Evidence, Potential Adverse Effects, and Known Drug
    ISSN: 2469-5742 Deol et al. Int Arch Urol Complic 2018, 4:047 DOI: 10.23937/2469-5742/1510047 Volume 4 | Issue 2 International Archives of Open Access Urology and Complications RESEARCH ARTICLE Supporting Evidence, Potential Adverse Effects, and known Drug Interactions of the Complementary Alternative Medicines which are Frequently used by Prostate Cancer Patients Harmeet Deol1, Alan Truong2, Tibebe Woldemariam3, Xiaodong Feng3 and Ruth Vinall3* 1PGY1 Resident, Corpus Christi Medical Center, USA 2Pharmacy student, California Northstate University College of Pharmacy (CNUCOP), Elk Grove, USA Check for 3Associate Professor, California Northstate University College of Pharmacy (CNUCOP), Elk Grove, USA updates *Corresponding author: Ruth Vinall, Associate Professor, California Northstate University College of Pharmacy (CNUCOP), Elk Grove, CA 95757, USA Abstract tory, and race (it is more common in African American A significant number of prostate cancer patients use com- plementary alternative medicines (CAMs) as an adjunct to men) [1]. In 2015, there were approximately 1,735,350 their conventional treatment. Examples of CAMs that are new cases diagnosed and it is estimated that 11.6% of frequently used by prostate cancer patients include green men will be diagnosed with PC at some point during tea extract, lycopene, and pomegranate fruit extract. In their lifetime [2]. Advances in early detection and treat- many cases there is little if any clinical study-based evi- dence to support the efficacy of CAMs in this setting, and, ment have contributed to improved patient outcomes; importantly, some CAMs can cause serious adverse effects in 1980 the 5-year survival rate was ~70.2%, the most when taken a high doses and/or have significant drug in- recent statistics estimate 5-year survival at 99.0% [2,3].
    [Show full text]
  • Saw Palmetto Serenoa Repens (W
    Clinical Overview Saw Palmetto Serenoa repens (W. Bartram) Small (syn. Sabal serrulata [Michx.] Nutt. ex Schult. & Schult. f.; Serenoa serrulata (Michx.) G. Nichols.) [Fam. Arecaceae] OVERVIEW NOTE:Most clinical studies have been Since the mid-1990s, saw palmetto has conducted with native extract. been one of the 10 top-selling herbs in the CONTRAINDICATIONS U.S. Total sales in mainstream retail stores in 2000 in the U.S. were over $43 million, Saw palmetto is contraindicated in ranking saw palmetto sixth in total herb advanced BPH with severe urinary sales. In Europe, saw palmetto extract is the retention. It should not be used without most commonly used phytotherapeutic first ruling out prostate cancer. agent for benign prostatic hyperplasia PREGNANCY AND LACTATION: Due to (BPH) and it is one of the most frequently potential hormonal activity, saw palmetto prescribed botanical preparations in is not recommended for pregnant or Germany. Saw palmetto berry was com- lactating women, although the herb is monly recommended for various prostatic seldom used by women. conditions by healthcare professionals in the early part of the 20th century. It was an ADVERSE EFFECTS official drug, listed in the United States Gastrointestinal disturbance occurs rarely. Pharmacopeia from 1906 to 1916 and in Ingestion of large amounts of saw palmetto the National Formulary from 1926 to 1950. berries may cause diarrhea, while ingestion In the 20th century, the United States of saw palmetto on an empty stomach may cause nausea. Hypertension was reported Dispensatory, 23rd edition, included saw Saw Palmetto palmetto as a treatment for enlargement of in 3.1% of patients taking the saw ® the prostate gland.
    [Show full text]
  • Prescription for Drug Alternatives All-Natural Options for Better Health Without the Side Effects
    ffirs.qxp 7/28/08 7:15 PM Page i Prescription for Drug Alternatives All-Natural Options for Better Health without the Side Effects JAMES F. BALCH, M.D. MARK STENGLER, N.D. ROBIN YOUNG BALCH, N.D. John Wiley & Sons, Inc. flast.qxp 7/28/08 7:16 PM Page viii ffirs.qxp 7/28/08 7:15 PM Page i Prescription for Drug Alternatives All-Natural Options for Better Health without the Side Effects JAMES F. BALCH, M.D. MARK STENGLER, N.D. ROBIN YOUNG BALCH, N.D. John Wiley & Sons, Inc. ffirs.qxp 7/28/08 7:15 PM Page ii Copyright © 2008 by J&R Balch, Inc., and Stenglervision, Inc. All rights reserved Published by John Wiley & Sons, Inc., Hoboken, New Jersey Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmit- ted in any form or by any means, electronic, mechanical, photocopying, recording, scan- ning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authoriza- tion through payment of the appropriate per-copy fee to the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 646-8600, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/ permissions.
    [Show full text]
  • Saw Palmetto Extract Laboratory Guidance Document
    Saw Palmetto Extract Laboratory Guidance Document By Stefan Gafner, PhD* American Botanical Council, PO Box 144345, Austin, TX 78714 Serenoa repens *Correspondence email Photo ©2019 Steven Foster Keywords: Adulteration, animal fatty acids, canola oil, coconut oil, palm oil, saw palmetto, Serenoa repens, sunflower oil, vegetable oil Citation (JAMA) style: Gafner S. Saw palmetto extract laboratory guidance document. Austin, TX: ABC-AHP-NCNPR Botanical Adulterants Prevention Program. 2019. 1. Purpose There is documented evidence of the adulteration of saw palmetto fruit extracts with a number of vegetable oils, such as canola (Brassica napus ssp. napus, Brassicaceae), coconut (Cocos nucifera, Arecaceae), olive (Olea europaea, Oleaceae), palm (Elaeis guineensis, Arecaceae), peanut (Arachis hypogaea, Fabaceae), and sunflower (Helianthus annuus, Asteraceae) oils. The partial or complete substitution of saw palmetto fruit extracts with mixtures of fatty acids of animal origin was first documented in 2018,1 and seems particularly common in materials sold as saw palmetto originating from China. This Laboratory Guidance Document (LGD) presents a review of the various analytical technologies used to differentiate between authentic saw palmetto extracts and ingredients containing adulterating materials. This document can be used in conjunction with the Saw Palmetto Botanical Adulterants Bulletin, rev. 3, published by the ABC-AHP-NCNPR Botanical Adulterants Prevention Program in 2018.2 2. Scope does not reduce or remove the responsibility of laboratory Various analytical methods are reviewed here with the personnel to demonstrate adequate method performance specific purpose of identifying their strengths and limita- in their own laboratories using accepted protocols. Such tions in differentiating saw palmetto fruit extracts from protocols are outlined in the United States Food and Drug potentially adulterating materials.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,166,300 B1 Dascalu (45) Date of Patent: Jan
    USOO71663 OOB1 (12) United States Patent (10) Patent No.: US 7,166,300 B1 Dascalu (45) Date of Patent: Jan. 23, 2007 (54) AGENT FOR INDUCING HAIR GROWTH EP O 640 333 A2 3, 1995 CONTAINING EXTRACTS OF SAW EP O640333 A2 * 3, 1995 PALMETTO AND SWERTIA JP 63. 27.5514 A 11, 1988 JP 63. 303913. A 12, 1988 (75) Inventor: Avi Dascalu, Tel-Aviv (IL) JP 09 10O220 A 4f1997 JP 4O910O220 A * 4f1997 (73) Assignee: Medidermis Ltd., Netanya (IL) WO WO9702041 A1 * 1, 1997 (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 OTHER PUBLICATIONS U.S.C. 154(b) by 77 days. Great American Products, “Hair Maximizer Solutions Program”. pp. 1-3.* (21) Appl. No.: 10/111,659 Effect of Retinoids on Follicular Cells, G. Bazzano et al., Journal of Investigative Dermatology, vol. 101, No. 1 Supp., Jul. 1993, pp. (22) PCT Filed: Oct. 19, 2000 138S-142S. Studies on Active Substances in Herbs. Used for Hair Treatment. I. (86). PCT No.: PCT/LOO/OO660 Effects of Herb Extracts on Hair Growth and Isolation of an Active Substance from Polyporus umbellatus F. Y. Inaoka et al., Chem. S 371 (c)(1), Phar. Bull. vol. 42, No. 3, 1994, pp. 530-533. Apr. 25, 2002 Topical Minoxidil Therapy for Androgenetic Alopecia, J. A. (2), (4) Date: Koperski et al., Arch Dermtol, vol. 123, Nov. 1987, pp. 1483-1487. SULTAN, Inhibition Of Androgen Metabolism And Binding By. A (87) PCT Pub. No.: WO01/30311 Liposterolic Extract Of "Serenoa Repens B" In Human Foreskin PCT Pub.
    [Show full text]